Identifying reliable cocaine addiction biomarkers is crucial for improving patient stratification and treatment outcomes in clinical practice. Traditional diagnostic tools often rely on subjective self-reports, which can limit the precision of interventions. However, a groundbreaking study published in European Addiction Research suggests that peripheral blood can provide objective diagnostic evidence through gene expression analysis.

Researchers conducted a cross-sectional study involving 349 participants to evaluate the predictive validity of dopamine-related mRNA transcription. Specifically, they compared 163 patients with moderate-to-severe cocaine use disorder (CUD) against 186 healthy controls. They measured transcription levels of several genes, including DRD2, DRD3, DRD4, and COMT. Notably, the study focused on how these markers relate to impulsivity and sensation-seeking traits.

Utilizing DRD2 as Cocaine Addiction Biomarkers

The findings demonstrated that CUD patients exhibit significantly elevated DRD2 mRNA levels in their peripheral blood. Furthermore, the presence of the DRD2-related rs6277 risk allele strongly correlated with a clinical CUD diagnosis. Consequently, this genetic marker provides a potential objective tool for identifying individuals at higher risk for severe addiction. Moreover, DRD2 mRNA levels showed a distinct relationship with self-reported impulsivity, which is a hallmark trait of addictive behavior.

Additionally, this research indicates that blood-based testing could revolutionize how clinicians monitor addiction recovery. Although further validation is necessary, these molecular signatures offer a window into the neurobiological status of the patient. Therefore, integrating these biomarkers into routine assessments may enhance the efficacy of personalized treatment plans. Healthcare providers can use these insights to better understand the individual differences in dopamine signaling among their patients.

Frequently Asked Questions

How can blood tests help diagnose cocaine use disorder?

Blood tests measure the mRNA transcription levels of specific dopamine-related genes like DRD2. Higher levels of this gene expression in the blood correlate with the presence and severity of cocaine use disorder, providing an objective diagnostic tool.

What role does the rs6277 allele play in addiction?

The rs6277 risk allele is a genetic variant of the DRD2 gene. Research indicates that individuals carrying this allele have a significantly higher risk of being diagnosed with cocaine use disorder, linking genetics directly to addiction susceptibility.

Are these biomarkers related to personality traits?

Yes, the study found that DRD2 mRNA levels in peripheral blood relate to self-reported impulsivity. This connection suggests that the biomarkers reflect both the clinical diagnosis and the underlying behavioral traits associated with addiction.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.

References

Kigar S et al. Peripheral expression of dopamine genes as a biomarker for cocaine addiction in humans. Eur Addict Res. 2026 Feb 21. doi: 10.1159/000551119. PMID: 41722074.

Volkow ND, Morales M. The Role of Dopamine in Drug Addiction. Lancet Psychiatry. 2015;2(8):719-725. doi:10.1016/S2215-0366(15)00150-2.

Nestler EJ, Lüscher C. The Molecular Basis of Drug Addiction. Neuron. 2019;102(1):41-59. doi:10.1016/j.neuron.2019.01.035.